Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …

T Santo, B Clark, M Hickman, J Grebely… - JAMA …, 2021 - jamanetwork.com
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …

[HTML][HTML] 'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue

S Clay, C Treloar, L Degenhardt, J Grebely… - International Journal of …, 2023 - Elsevier
Introduction Long-acting injectable depot buprenorphine is a recent addition to the suite of
opioid agonist therapies (OAT) used to treat opioid use disorder (OUD). However, there has …

[HTML][HTML] Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study

KB Malme, K Ulstein, AK Finbråten… - International Journal of …, 2023 - Elsevier
Background Improving HCV treatment uptake among people who inject drugs (PWID) is
crucial to achieving the WHO elimination targets. The aims were to evaluate HCV treatment …

Should I stay or should I Go? A qualitative exploration of stigma and other factors influencing opioid agonist treatment journeys

VR Carlisle, OM Maynard, D Bagnall… - International Journal of …, 2023 - mdpi.com
Highlights OAT treatment journeys in our sample were influenced by a broad range of
individual, social and structural factors, with stigma presenting a pervasive barrier to …

Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak

KMA Trayner, NE Palmateer, A McAuley… - International Journal of …, 2021 - Elsevier
Background: A large outbreak of HIV among people who inject drugs (PWID) has been
ongoing in Glasgow city centre (GCC), Scotland since early 2015. The outbreak is …

Characterizing people who inject drugs with no history of opioid agonist therapy uptake in Iran: results from a national bio-behavioural surveillance survey in 2020

F Mehrabi, S Mehmandoost, A Mirzazadeh… - International journal of …, 2024 - Springer
Injection drug use is the primary driver of the HIV epidemic in Iran. We characterized people
who inject drugs (PWID) living in Iran who had never received opioid agonist therapy (OAT) …

Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study …

EU Patel, SM Grieb, AK Winiker, J Ching… - Harm reduction …, 2024 - Springer
Background Substance use disorder treatment and recovery support services are critical for
achieving and maintaining recovery. There are limited data on how structural and social …

Past-year HIV testing, current antiretroviral therapy use, and participation in services for people who inject drugs

I Sokale, J Wilkerson, P Wermuth, F Atem, J Burnett… - AIDS and Behavior, 2024 - Springer
Evaluating routine HIV testing and treatment and use of services for people who inject drugs
(PWID) is critical to curb the ongoing HIV epidemic. We analyzed data from the 2018 …

Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report

L Wiessing, P Banka-Cullen, MG Barbaglia… - International Journal of …, 2023 - Springer
Non-medical opioid use is a major public health concern causing high mortality. While
opioid agonist maintenance treatment (OMT) is a key life-saving intervention, there is (a) no …

Modelling the impact of prevention and treatment interventions on HIV and hepatitis C virus transmission among people who inject drugs in Kenya

J Stone, H Fraser, JG Walker, N Mafirakureva… - MedRxiv, 2021 - medrxiv.org
Background People who inject drugs (PWID) in Kenya have a high prevalence of HIV (14-
26%) and HCV (11-36%). Needle and syringe programmes (NSP) and antiretroviral therapy …